From Molecules to Patients: The Clinical Applications of Translational Bioinformatics

OBJECTIVE In order to realize the promise of personalized medicine, Translational Bioinformatics (TBI) research will need to continue to address implementation issues across the clinical spectrum. In this review, we aim to evaluate the expanding field of TBI towards clinical applications, and define common themes and current gaps in order to motivate future research. METHODS Here we present the state-of-the-art of clinical implementation of TBI-based tools and resources. Our thematic analyses of a targeted literature search of recent TBI-related articles ranged across topics in genomics, data management, hypothesis generation, molecular epidemiology, diagnostics, therapeutics and personalized medicine. RESULTS Open areas of clinically-relevant TBI research identified in this review include developing data standards and best practices, publicly available resources, integrative systemslevel approaches, user-friendly tools for clinical support, cloud computing solutions, emerging technologies and means to address pressing legal, ethical and social issues. CONCLUSIONS There is a need for further research bridging the gap from foundational TBI-based theories and methodologies to clinical implementation. We have organized the topic themes presented in this review into four conceptual foci - domain analyses, knowledge engineering, computational architectures and computation methods alongside three stages of knowledge development in order to orient future TBI efforts to accelerate the goals of personalized medicine.

[1]  Richard Simon,et al.  Implementing personalized cancer genomics in clinical trials , 2013, Nature Reviews Drug Discovery.

[2]  Bairong Shen,et al.  Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era , 2013, BioMed research international.

[3]  Mehmet Koyutürk,et al.  Network biology methods integrating biological data for translational science , 2012, Briefings Bioinform..

[4]  Emidio Capriotti,et al.  Bioinformatics for personal genome interpretation , 2012, Briefings Bioinform..

[5]  Leroy Hood,et al.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.

[6]  Maricel G. Kann,et al.  Chapter 4: Protein Interactions and Disease , 2012, PLoS Comput. Biol..

[7]  Ju Han Kim New horizons in translational bioinformatics: TBC 2013 , 2014, BMC Medical Genomics.

[8]  L. Lesko Drug Research and Translational Bioinformatics , 2012, Clinical pharmacology and therapeutics.

[9]  Xu Han,et al.  Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions , 2012, PLoS Comput. Biol..

[10]  Indra Neil Sarkar,et al.  A vector space model approach to identify genetically related diseases , 2012, J. Am. Medical Informatics Assoc..

[11]  Y. Joly,et al.  Opportunities and Challenges Provided by Cloud Repositories for Bioinformatics‐Enabled Drug Discovery , 2014, Drug development research.

[12]  Madeleine Udell,et al.  Analyzing Patterns of Drug Use in Clinical Notes for Patient Safety , 2012, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

[13]  Suresh K. Bhavnani,et al.  iCircos: visual analytics for translational bioinformatics , 2012, IHI '12.

[14]  Ara Darzi,et al.  Preparing for precision medicine. , 2012, The New England journal of medicine.

[15]  Francisco Azuaje,et al.  Drug interaction networks: an introduction to translational and clinical applications. , 2013, Cardiovascular research.

[16]  Martin Hofmann-Apitius,et al.  Challenges and opportunities for oncology biomarker discovery. , 2013, Drug discovery today.

[17]  S. Sudarsanam,et al.  Translational biology approach to identify causative factors for rare toxicities in humans and animals. , 2012, Current drug discovery technologies.

[18]  M. Khoury,et al.  “Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[19]  Mark A. Musen,et al.  Chapter 9: Analyses Using Disease Ontologies , 2012, PLoS Comput. Biol..

[20]  Matthew S. Lebo,et al.  A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record , 2013, Genetics in Medicine.

[21]  Philip R. O. Payne Chapter 1: Biomedical Knowledge Integration , 2012, PLoS Comput. Biol..

[22]  Christopher G. Chute,et al.  Some experiences and opportunities for big data in translational research , 2013, Genetics in Medicine.

[23]  P. Sanseau,et al.  Computational Drug Repositioning: From Data to Therapeutics , 2013, Clinical pharmacology and therapeutics.

[24]  Kip Nalley,et al.  Tissue Banking, Bioinformatics, and Electronic Medical Records: The Front-End Requirements for Personalized Medicine , 2013, Journal of oncology.

[25]  A. Butte,et al.  Translational Bioinformatics: Data‐driven Drug Discovery and Development , 2012, Clinical pharmacology and therapeutics.

[26]  Bairong Shen,et al.  Translational Biomedical Informatics in the Cloud: Present and Future , 2013, BioMed research international.